CZMWF (Carl Zeiss Meditec AG) EPS (Basic): $1.55 (TTM As of Dec. 2025)


CZMWF Carl Zeiss Meditec AG CZMWF
70 GF Score
Price $31.42
GF Value $85.82
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG EPS (Basic)?

Carl Zeiss Meditec AG CZMWF 70 EPS (Basic) is $1.55 as of Dec. 2025. GuruFocus rates CZMWF with a GF Score™ of 70/100 and a GF Value™ of $85.82 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Carl Zeiss Meditec AG's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was $-0.07. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was $1.55.

Carl Zeiss Meditec AG's EPS (Diluted) for the three months ended in Dec. 2025 was $-0.07. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $1.55.

Carl Zeiss Meditec AG's EPS without NRI for the three months ended in Dec. 2025 was $-0.07. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 1.55.

During the past 12 months, Carl Zeiss Meditec AG's average EPS without NRIGrowth Rate was -22.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was -23.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Carl Zeiss Meditec AG's highest 3-Year average EPS without NRI Growth Rate was 27.00% per year. The lowest was -23.30% per year. And the median was 7.20% per year.

Carl Zeiss Meditec AG  (OTCPK:CZMWF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Carl Zeiss Meditec AG EPS (Basic) Related Terms

Carl Zeiss Meditec AG EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG EPS (Basic) Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.11 3.26 3.47 2.23 1.89

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.19 0.56 0.37 0.69 -0.07
CZMWF
70GF Score
Carl Zeiss Meditec AG CZMWF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Carl Zeiss Meditec AG's Basic EPS for the fiscal year that ended in Sep. 2025 is calculated as

Basic EPS (A: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(165.739-0)/87.536
=1.89

Carl Zeiss Meditec AG's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-5.738-0)/81.667
=-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $1.55 mean?
Carl Zeiss Meditec AG (CZMWF) has a EPS (Basic) of $1.55 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Carl Zeiss Meditec AG and its competitors.
Is Carl Zeiss Meditec AG's EPS (Basic) too high?
Carl Zeiss Meditec AG's current EPS (Basic) is $1.55. Overall, Carl Zeiss Meditec AG has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's EPS (Basic) compare to ISRG and BDX?
Carl Zeiss Meditec AG's EPS (Basic) of $1.55 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Medical Devices & Instruments company?
A good EPS (Basic) depends on the Medical Devices & Instruments industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Carl Zeiss Meditec AG and its competitors. Carl Zeiss Meditec AG's current EPS (Basic) is $1.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (CZMWF) is currently considered Significantly Undervalued. The stock's GF Value™ is $85.82, compared to a current price of $31.42 — trading 63.4% below its estimated fair value. The current EPS (Basic) is $1.55. Carl Zeiss Meditec AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Carl Zeiss Meditec AG (CZMWF), the current EPS (Basic) is $1.55 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carl Zeiss Meditec AG (CZMWF) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of $31.42 is trading 63.4% below its estimated GF Value™ of $85.82. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for CZMWF:

  • EPS (Basic): $1.55
  • GF Value™: $85.82 vs. price of $31.42 (63.4% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the CZMWF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
70GF Score

Get the complete analysis for CZMWF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.42
Price
$85.82
GF Value